| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 07/03/2002 | EP0759436B1 Process for the preparation of beta-lactam derivative |
| 06/27/2002 | WO2002050090A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 06/27/2002 | WO2002050068A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | WO2002050060A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | WO2002050056A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/27/2002 | WO2002050046A1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 06/27/2002 | WO2002050027A1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 06/27/2002 | WO2002050025A1 PROCESS FOR SYNTHESIZING β-LACTAM |
| 06/27/2002 | WO2002022592A3 Substituted urea neuropeptide y y5 receptor antagonists |
| 06/27/2002 | US20020082250 Beta lactams as antiproliferative agents |
| 06/27/2002 | CA2431995A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | CA2431985A1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 06/27/2002 | CA2431588A1 Benzylamine derivatives and their use as thrombin inhibitors |
| 06/25/2002 | US6410594 Viricides |
| 06/19/2002 | EP1214296A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/18/2002 | US6407228 Method for the preparation of β-lactam compound |
| 06/13/2002 | WO2002046199A1 Process and ester derivatives useful for preparation of cephalosporins |
| 06/13/2002 | WO2002006221A3 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 06/12/2002 | EP1212054A2 Azetidine compounds in cns and eye diseases |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0688212B1 C9 taxane derivatives and pharmaceutical compositions containing them |
| 06/11/2002 | US6403632 Cyclic amide derivative |
| 06/11/2002 | US6403575 3-Pyridyl enantiomers and their use as analgesics |
| 06/11/2002 | US6403574 Tranquilizers, antiepileptic, muscle relaxation prior to surgery |
| 06/11/2002 | US6403573 Compounds of azetidine and pyrrolidin |
| 06/06/2002 | WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors |
| 06/06/2002 | WO2002044113A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | US20020068730 New amidino derivatives and their use as thormbin inhibitors |
| 06/06/2002 | CA2430199A1 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/05/2002 | EP0970049B1 Process for the production of enantiomerically enriched n-acylazetidine-2-carboxylic acids |
| 05/30/2002 | US20020065417 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds |
| 05/28/2002 | USRE37721 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/28/2002 | US6395895 Butenyl substituted β-lactams |
| 05/28/2002 | US6395894 Process for the synthesis of carbapenem intermidiates, and compounds produced |
| 05/22/2002 | CN1350522A New process |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/10/2002 | WO2002036157A1 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders |
| 05/10/2002 | CA2428012A1 Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055543 Inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor; useful in treating diseases including asthma, arthritis, and sepsis. |
| 05/07/2002 | US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 05/07/2002 | US6384063 Compound having effect of promoting neuron differentiation |
| 05/02/2002 | US20020052511 Process for the preparation of matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1201670A2 Process for preparing 2-oxaisocephem derivatives |
| 05/02/2002 | EP1201669A2 Process for preparing halogenated cephem derivatives |
| 05/02/2002 | EP1201654A2 Process for preparing allenyl beta-lactam derivatives |
| 05/02/2002 | EP1201653A1 Method for racemization of optically active azetidine-2-Carboxylate |
| 05/02/2002 | EP1201649A1 Glucocorticoid receptor modulators |
| 05/01/2002 | CN1083833C Sulfur-substd. azetidinone compounds useful as hypocholesterolemic agents |
| 04/25/2002 | WO2002032377A2 Estrogen receptor modulators |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | US20020049315 Crystalline forms of carbapenem intermediates |
| 04/25/2002 | CA2424729A1 Estrogen receptor modulators |
| 04/23/2002 | CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/17/2002 | EP1196431A1 A substantially crystalline form of melagatran |
| 04/17/2002 | EP1196166A1 Azetidine carboxamide derivatives for the treatment of cns disorders |
| 04/17/2002 | EP1196165A2 Azetidine compounds in cns and eye diseases |
| 04/11/2002 | WO2002028829A2 Peptide deformylase inhibitors |
| 04/11/2002 | WO2002028815A1 Pharmaceutical compounds |
| 04/11/2002 | US20020042508 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 04/11/2002 | US20020042431 Zwitterionic tachykinin receptor antagonists |
| 04/11/2002 | US20020042408 Antibiotic compounds |
| 04/11/2002 | US20020042396 Amino acid derivatives |
| 04/11/2002 | CA2419777A1 Pharmaceutical compounds |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | CN1344329A Stereoselective microbial reduction for prpn. of 1-(4-fluorophenyl)-3(R)-[3(s)-hydroxy-3-(4-fluorophenyl)propyl)-4(s)-(-4hydroxyphenyl)-2-azetidinone |
| 04/09/2002 | US6369244 C13 amido substituted taxane derivatives and pharmaceutical compositions containing them |
| 04/04/2002 | WO2002026750A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 04/04/2002 | WO2002026720A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026705A2 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 04/04/2002 | US20020040016 Derivatives of azetidine and pyrrolidine |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/03/2002 | EP1193253A1 Process for producing optically active azetidine-2-carboxylic acids |
| 04/03/2002 | EP1193252A2 Beta-Lactams useful for preparation of substituted isoserine esters using metal alkoxides |
| 04/03/2002 | CN1343217A New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2002024629A1 Zwitterionic tachykinin receptor antagonists |
| 03/28/2002 | WO2002024197A1 Fatty acid synthase inhibitors |
| 03/28/2002 | DE10042447A1 Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports Protein from the intestines of vertebrates, which absorbs cholesterol, as well as use of this protein for the identification of inhibitors of intestinal cholesterol transport |
| 03/28/2002 | CA2423356A1 Zwitterionic tachykinin receptor antagonists |
| 03/21/2002 | WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/21/2002 | WO2002022572A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 03/21/2002 | WO2002022549A1 Process for the removal of nitrobenzenesulfonyl |
| 03/21/2002 | US20020035102 Azetidine derivatives, their preparation and medicaments containing them |
| 03/21/2002 | CA2422055A1 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| 03/21/2002 | CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 03/20/2002 | EP1187810A2 Heterocyclic analgesic compounds and their use |
| 03/20/2002 | EP1187809A1 Process for reduction of (2r)-4-oxoazetidinone-2-carboxylic acid |
| 03/19/2002 | US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections |
| 03/14/2002 | WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | WO2002020476A2 Crystalline forms of carbapenem intermediates |
| 03/14/2002 | US20020032338 Enantiomerically pure compounds by reacting water and carbocycle or heterocycle having an electrophilic center in the presence of an asymmetric tetradentate ligand complexed with a metal atom, which has a geometric shape |
| 03/14/2002 | CA2421116A1 Crystalline forms of carbapenem intermediates |
| 03/14/2002 | CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |